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Utilizing a stromal-derived inducing activity (SDIA) model of neurogenesis, we 
investigated the effects of the targeted knockdown of Oct-3/4 and Sox-2 by short 
interfering RNAs (siRNAs) in mouse embryonic stem cells (mESC). Quantitative 
real-time PCR showed a 40-90% knockdown of specific transcripts with cognate Oct-
3/4 or Sox-2 siRNA transfection compared to FAM-labelled negative control (FAM) 
siRNAs or mock transfection, and was confirmed at the protein level by Western blot 
analysis.  Using PA6 SDIA co-cultures, neurogenesis was significantly diminished in 
Oct-3/4 or Sox-2 targeted mESC  upon differentiation. We observed that 45±12%, 
65±13% and 90±8% (Mean +/- SD) of the colonies were stained with neuron-specific 
β-tubulin III in Oct-3/4, Sox-2, and FAM siRNA transfected mESC respectively.  
Similar results were observed when differentiating mESC with neural-inducing 
factors (Hep-NIF) collected from the surface of PA6 cells using heparin.  In addition, 
differentiation of mESC using Hep-NIF but not Oct-3/4 and Sox-2 knockdown led to 
the pronounced appearance of discrete, dark granular glial acidic fibrilary protein 
(GFAP)-positive cells which also expressed the glial cell marker Vimentin. Taken 
together, these results extend the role of Oct-3/4 in SDIA, implicate a similar role for 
Sox-2, and support emerging observations for the role of these factors and SDIA in 
gliogenesis. 
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Mouse embryonic stem cells (mESC) are uniquely capable of differentiating into all 
somatic cell types in the body, a property known as pluripotency.  In addition, mESC 
are known to grow indefinitely in culture without reaching senescence.  The 
pluripotent capability of mESC has been particularly useful in the generation of 
transgenic or knockout mice, and have allowed the establishment of in vitro 
developmental and cellular differentiation models such as those for neurogenesis.   
 
The propensity of mESC to preferentially differentiate into neurons provides evidence 
for a “default model” of neurogenesis (Munoz-Sanjuan and Brivanlou, 2002).  This 
model proposes that embryonic stem (ES) cells for various species do not require 
external factors such as fibroblast growth factors (FGFs) or wingless homologues 
(WNTs) to instruct ES cells to become neuronal subtypes, but rather that ES cells 
preferentially differentiate into neuronal subtypes by default, and are prevented from 
doing so by the presence of neurogenesis-inhibiting bone morphogenic proteins 
(BMPs).  In Xenopus explant experiments, an autologously transplanted Spemann 
Organizer (a potent source of various BMP inhibitors) has been shown to be able to 
elicit neurogenesis in the recipient region. The default model further proposes that the 
apparent capability of FGFs and WNTs to differentiate ES cells into neuronal 
subtypes is largely attributable to BMP inhibition, thereby releasing ES cells to 
differentiate into their preferential neuronal subtypes and not due to any direct cellular 
fate specification (Tropepe et al., 2001).  The latter function has been described as an 
“instructive model” and is largely supported by chicken models in which explants 
similar to Xenopus are incapable of eliciting a similar “default” response.  A 
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combination of FGFs and WNTs are requisite for neurogenesis, suggesting therefore 
that these factors to have a deterministic rather than an accessory role in neuronal 
subtype differentiation.   
 
While exogenous factors clearly have a role in ES cellular fate specification, our 
understanding of a default or instructive model would be greatly aided by a better 
understanding of the transcription factors regulating ES cell pluripotency, 
immortality, and neuronal differentiation.  Of great interest are pluripotent 
transcription factors such as Oct-3/4 and Sox-2 and their possible roles in transiting 
the boundary from an ES cell to a neuronal, or other, cellular derivatives.  The Pit-
Oct-Unc (POU) transcription factor Oct-3/4, and Sox-2, a high mobility group (HMG) 
protein, are thought to be important factors in maintaining ES cell identity. This 
hypothesis is however controversial as some contradictory reports suggest the  
necessity of a sustained expression of Oct-3/4  (also known as Pou5F1) for  
neurogenesis (Shimozaki et al., 2003) and that constitutive Sox-2 expression enhances 
neuronal differentiation (Sasai, 2001; Zhao et al., 2004). 
   
The apparent pleiotropy of these transcription factors in maintaining a pluripotent 
mESC identity may result from a diversity of binding to multiple transactivation 
targets.  While various mESC transcription factors, including Stat-3, FoxD3, Oct-3/4, 
Sox-2 and Nanog have all been demonstrated to be involved in maintaining a 
pluripotent phenotype (Cavaleri and Scholer, 2003), the apparent inability of any 
single given factor to maintain mESC pluripotency suggests the possibility of shared 
transactivation targets.  
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It is worth noting that transactivation target studies that have utilized Oct-3/4 and 
Sox-2 as probes are few and some are performed in non stem cell types which may 
not resemble biological responses in mESC.  Canonical targets of Oct-Sox 
transactivation include Utf-1, Fgf-4, Opn, Fbx-15 (Botquin et al., 1998; Okuda et al., 
1998; Tokuzawa et al., 2003; Yuan et al., 1995).  However, the overexpression of any 
of these transactivation targets was neither permissive nor deterministic for a 
pluripotent mESC phenotype.  Thus, it is unclear how the multitude of cellular fates 
potentially arising from the differentiation of mESC could be specified by these 
targets.   
 
Recent reports suggesting a significantly larger number (~2000) of putative binding 
targets between Oct-3/4, Sox-2, and Nanog than previously suspected could provide a 
significant clue to the biochemical dynamics underlying the choice of cell fate on 
mESC differentiation (Boiani and Scholer, 2005; Boyer et al., 2005; Loh et al., 2006). 
It is worthy to note that the transactivation or silencing of these binding targets, as a 
result of the combinatorial interactions of Oct-Sox-Nanog binding, has yet to be 
definitively shown (Remenyi et al., 2004).  
 
This thesis explores the roles of Oct-3/4 and Sox-2 during cellular fate specification 
of mESC in a neurogenesis model using the stromal cell line, PA6, as well as small, 
interfering (siRNA) and short hairpin RNAs (shRNA) to inhibit the expressions of 
Oct-3/4 and Sox-2 in differentiating mESC.  We also measured the expression levels 
of some canonical Oct-Sox targets with the intention of determining their potential 





1. Culturing of Mouse Embryonic Stem Cells (mESC) 
 
a. Culturing Conditions  
 
Initial culturing methods for mESC required a layer of co-cultured fibroblasts to 
provide a biochemical and physical support for undifferentiated proliferation; such 
cells (“feeders”) were inactivated using either mitomycin C (which crosslinks 
thymidine) or radiation to prevent proliferation, overgrowth, and competition for cell 
culture materials.  We successfully cultured mESC on mitomycin C-treated STO 
feeders in this condition (Figure 1).  An alternate culturing method, requiring 
supplementation of exogenous leukemia inhibitory factor (LIF), was permissive of 
undifferentiated mESC proliferation in the absence of feeders.  In this condition, 
mESC retained a smooth, bright, round colony morphology (Figure 1B) and could be 
established following routine passaging of mESC onto gelatin-coated tissue culture 
surfaces.  Previously co-cultured, but unproliferative mitomycin C feeder layers were 
eventually removed through 2-3 subsequent passages.  mESC grown in this condition 
could be spontaneously differentiated into embryoid bodies (EB) in suspension 
following plating onto bacterial Petri dishes (Figure 1C); EB generation is a common 
first step in establishing a heterogenous population of differentiated cells that can 
subsequently be selected or channeled for derivation into the cell type of interest 


















Figure 1. Culturing conditions of mESC (AB2.2). (A) mESC grown on STO-
Neomycin-LIF feeders exhibited a bright, round, compact cluster morphology. (B) 
Supplementation of exogenous Leukemia Inhibitory Factor (LIF) was sufficient to 
maintain mESC morphology. Unproliferative feeders were not present after 2-3 
passages. (C) mESC were placed onto bacterial petri dishes and grew in suspension as 
embryoid bodies (EB), which were sequentially selected for or directed into 




b. Expression of Oct-3/4, Alkaline Phosphatase, and SSEA-1 
 
Early identification and characterization of pluripotent mESC was aided by the 
establishment of biochemical markers including, Oct-3/4, alkaline phosphatase (AP), 
and stage-specific embryonic antigen-1 (SSEA-1), which were detectable in our 






required for a pluripotent phenotype. Removal of support conditions (fetal bovine 
serum or LIF) was found to result in a decrease in Oct-3/4 expression and the 
inhibition of expression resulted in differentiation (see below).  Interestingly, forced 
expression of Oct-3/4 in concert  with removal of support factors is not sufficient to 
maintain a pluripotent phenotype (Chambers, 2004), suggesting Oct-3/4 alone is 
insufficient to maintain stem cell identity. Other factors which are LIF dependent, but 
Oct-3/4 independent, may be required for the pluripotent phenotype.  Upon LIF 
removal for 1 week, AP expression was found to decrease, and the decrease in Oct-

















Figure 2. Pluripotent mESC markers, Oct-3/4, Alkaline Phosphatase (AP), and 
Stage-Specific Embryonic Antigen-1 (SSEA-1) are readily detectable in E14 cells. 
(A) mESC showed high levels of intracellular Oct-3/4 expression (dotted lines) as 
compared to isotype control (solid line). (B) Immunofluorescence of AP marker for 
pluripotent mESC showed the predicted expression in the cultures, as well as (C) 
SSEA-1, a surface antigen specific for pluripotent mESC.  Both E14 and AB2.2 
showed similar profiles. 
B Alk. Phos. 



























Figure 3. LIF withdrawal caused mESC (E14) differentiation. (A) Alkaline 
Phosphatase expression, viewed using phase contrast microscopy, decreased 
following 1 week of LIF withdrawal from mESC cultures. (B) LIF withdrawal also 
decreased Oct-3/4 expression within 2-3 weeks as shown. Dashed lines are pluripotent 
mESC, solid line is mESC following LIF withdrawal, and dotted line is isotype 
control.  Numbers indicated are percentage of Oct-3/4 positive cells among LIF 
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Oct-3/4 Expression 
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2. Neurogenesis Using PA6 Stromal-Derived Inducing Activity  
 
a. PA6 Co-Culture Method 
 
Mouse embryonic stem cells are able to differentiate into a wide variety of cell types, 
including neuroectodermal derivatives, using a variety of methods: retinoic acid 
treatment, gene trap lineage promoter-selection, or co-culture with stromal cell types 
including PA6 (Kawasaki et al., 2000; Okabe et al., 1996).  A skull marrow cell line, 
PA6 was originally identified as enabling highly efficient (>90% colonies) 
differentiation of mESC into tyrosine hydroxylase (TH)-positive neuron-like cells.  
We utilized PA6 co-cultures to differentiate mESC into neuron-like cells staining 
positive for Neurofilament Light Chain (NF-L), TH, and neuron-specific β-tubulin III 
(Tuj1) markers (Figure 4).  Neuron-like cells expressing TH are of particular interest 
given their apparent destruction in Parkinson’s Disease (PD) pathology (Bjorklund et 
al., 2003).  The capability of PA6 to differentiate pluripotent mESC into TH+ neuron 
like cells, termed stromal-derived inducing activity (SDIA), is based on the 
production of unknown biological factors.  Initial reports described a factor present on 
the surface of PA6, as medium conditioned by PA6 is incapable of differentiating 
mESC.  However, it was reported that a permeable physical barrier (membrane filter) 
between PA6 and mESC cells was still permissive for the differentiation of mESC to 
TH+/ TuJ1+ cell types suggesting that a tethered labile factor might account for these 














Figure 4. PA6 Stromal-Derived Inducing Activity (SDIA) co-culture. Mouse 
embryonic stem cells seeded onto PA6; the latter were visible as flat, dark patches of 
cells beyond the bright, round cluster morphology of differentiating neurospheres.  
Extended processes were visible under bright field and immunostained for 
Neurofilament Light Chain (NF-L), a neuron-specific marker.  Neurospheres also 
stained positive for the dopaminergic marker tyrosine hydroxylase (TH) as well as 
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b. Heparin Neural-Inducing Factor (Hep-NIF) SDIA Feeder-Free Method 
 
More recently, the potency of SDIA has been extended through the use of a heparin-
PBS solution incubated with PA6 to isolate/collect differentiating factors from the cell 
surface.  These previously incubated solutions (termed neural-inducing factors, 
“NIFs”) can subsequently be added to serum-free mESC cultures for neuroectodermal 
differentiation, albeit with a reduced efficiency when compared to direct plating of 
mESC onto PA6 cells. Co-cultures of PA6 and heparin feeder-free (Hep-NIF) SDIA 
generated 80-90% and 30-50% TH+/ TuJ1+ colony differentiation, respectively 
(Yamazoe et al., 2005).   Utilizing heparin-PBS solutions of varying concentrations, 
we established Hep-NIF SDIA differentiation in our mESC cultures.  Consistent with 
previous reports (Yamazoe et al., 2005), treatment of NIFs resulted in the formation 
of neuron-like cell clusters (neurospheres) with extended processes. Only a small 
number of neuron-like cell clusters was observed with PBS incubated with PA6 and 
not observed at all with PBS alone (Figure 5A).  These processes stained positive for 
neuron-specific TuJ1, with large extensions observed between neurospheres and the 
individual cells within (Figure 5B).   It was previously reported that higher 
concentrations of heparin were inhibitory for efficient TuJ1+ neurosphere formation.  
We observed similar results where 100 ug/mL heparin SDIA solutions resulted in 
extension of processes visible under bright field, but patches of large, flat cells similar 
to those generated in PBS controls were visible (Figure 5A).   Expression of TuJ1 was 
also significantly enhanced in mESC differentiated using Hep-NIF as compared to 



























Figure 5. Heparin Neural-Inducing Factor (Hep-NIF) feeder free SDIA. (A) 
Heparin-SDIA differentiation using 100 or 10 µg/mL Heparin-PBS solution 
previously incubated with PA6 (Hep-NIF), PBS with and without PA6 incubation 
(PBS-NIF and PBS, respectively).  PBS solution alone showed few processes and 
increasing amounts with PBS-NIF, 100 µg / mL Hep-NIF and 10 µg / mL Hep-NIF, 
respectively (similar to the original report of Yamazoe et al., 2005).  (B) Usage of 10 
µg / mL Hep-NIF solution added to serum-free differentiation media to differentiate 
mESC resulted in brightly stained TuJ1+ colonies with processes extending between 
and within differentiating neurospheres.  High magnification within differentiating 
neurospheres revealed polar cell bodies characteristic of neuron-like cells.   All results 




100 µg/ml Hep-NIF 10 µg/ml  Hep-NIF 











Figure 6. Western blot detection of TuJ1 in Hep-NIF differentiated mESC.  
Significantly higher expression of TuJ1 was detected using Western blot in mESC 
differentiated using Hep-NIF compared to PBS-NIF control.  This was consistently 






























3. Knockdown of Oct-3/4 and Sox-2 Transcription Factors in Mouse 
Embryonic Stem Cells  
 
a. Establishment of Efficient Transfection Method  
 
In order to determine potential roles for Oct-3/4 and Sox-2 in neurogenesis, we 
established a robust RNAi knockdown method using siRNAs.  Several factors can 
contribute to the failure of an RNAi knockdown, including most commonly, 
inappropriate siRNA design and poor transfection efficiency (Elbashir et al., 2002).  
As an example of the latter, even if 60% of cells are properly transfected, and an 80% 
knockdown occurs within that population, this would only equate to a theoretical 48% 
decrease in total transcript expression.  This may or may not be reproducibly detected 
due to the one cycle (two-fold) differential limit of qRT-PCR detection.   
 
We developed a simple means to optimize transfection conditions by utilizing FAM 
oligodT to determine the efficiency of uptake in mESC colonies following the 
transfection of several commercial reagents. These included liposomal (Invitrogen 
Oligofectamine™/Lipofectamine 2000™, Bio-Rad Transfectin™, Roche Fugene 6™, 
and New England Biolabs Transpass™), cationic polymer (Fermentas Exgen™), and 
CaPO4 reagents, all of which were utilized according to the manufacturers’ protocols.  
 
mESC when seeded overnight and transfected at approximately 40% confluency 
failed to be transfected by Transpass™, Oligofectamine™ and Fugene 6™ when 
observed at 2 and 12 hours post-transfection, while Exgen™ transfection was only 
observable after 12 hours (Figure 8).  Liposomal delivery methods, including 
Lipofectamine 2000™ and Transfectin™, as well as CaPO4 were able to transfect a 
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small number of colonies (<10%) when observed at 2 hours and increased marginally 
at 12 hours post-transfection (Figure 7 and 8, respectively).  It was observed that 
CaPO4 and Exgen™ formed large deposits of FAM oligodT on the tissue culture 
surface surrounding of mESC colonies (Figure 8).  Furthermore, Transfectin™ 
appeared to transfect slightly better than Lipofectamine™ 2000 two hours after 
transfection (Figure 7).  In all cases of FAM oligodT transfection, it was observed that 
the transfected cells were often relegated to the periphery of mESC colonies.  This is 
presumably due to low accessibility of transfection complexes to membrane surfaces 































Figure 7. Detection of FAM oligodT after two hours. mESC (E14 cells) were 
seeded onto 96-well plates, cultured overnight, transfected with various commercial 
reagents and subsequently visualized by fluorescent microscopy at 2 hours. Except for 
Bio-Rad Transfectin™, CaPO4 and Lipo2K did not show significant transfection of 
FAM oligodT. 
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Figure 8. Detection of FAM oligodT after twelve hours. Significantly more mESC 
(E14) were transfected with FAM oligodT at 12 hours post-transfection for all 








As such, we investigated whether rapid transfection shortly after seeding (4 hours) 
would improve transfection efficiency.  It was observed that using this method, 
virtually all (>90%) mESC colonies were successfully transfected with FAM oligodT 
when observed 12 hours post-transfection; interestingly, the presence of FAM 
oligodT was not localized to the periphery (Figure 9A).  We further extended this 
approach to transfection of mESC using plasmid vectors.  Upon rapid transfection 
with GFP-C2 vector (Clontech), virtually all (>90%) of mESC colonies showed GFP 






























Figure 9. Establishment of an efficient mESC transfection method. Rapid 
transfection at 4 hours post-seeding resulted in high transfection efficiency using (A) 
FAM labelled negative control siRNA and (B) GFP-C2 vector. 
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Following successful establishment of an improved transfection method for mESC, 
we transfected Invitrogen Stealth™ siRNAs cognate to Oct-3/4 (siOct) and separately 
with FAM-labelled siRNA negative control.  The latter is particularly useful as it 
indicates both the efficiency of transfection and also serves as a non-cognate siRNA 
to control for the possibility of non-specific RNAi interactions.  Two cognate designs 
for Oct-3/4 were utilized to eliminate the possibility of design-specific inefficiency or 
non-specificity.  Measurement via qRT-PCR demonstrated nearly complete 
abolishment (>90%) of Oct-3/4 mRNA transcripts with either siOct design, 24 hour 
post-transfection and 4 hours after seeding (Figure 10A, left panel), an improvement 
compared to the 40% knockdown observed utilizing transfection following overnight 
seeding (Figure 10B, right panel).    We also observed that Oct-3/4 transcript could be 
effectively degraded using ~30 picomoles of siRNA in less than 24 hours despite the 
high expression levels in control cells. It is perhaps surprising that the expression 
level of Oct-3/4 is comparable to the endogenous control, Gapdh (Figure 10B).  
Western blot analyses paralleled the knock-down of Oct-3/4 transcript which showed 
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Figure 10. Transient siRNA knockdown of Oct-3/4. (A) Quantitative real-time PCR 
measurement of Oct-3/4 in mESC (E14) using ABI Taqman probe, 24 hours post- 
transfection of FAM, siOct-A and siOct-B siRNAs following 4 hours and overnight 
seeding. Values reported are ∆∆Ct normalized to multiplexed endogenous ABI Gapdh 
VIC detection and calibrated against FAM siRNA control with 95% confidence 
interval as shown.  * indicates p < 0.05 when compared to FAM control and is 
representative of 2 independent experiments. (B) Quantification of Gapdh 
amplification (Pink) and Oct-3/4 (Green) amplification in a single multiplexed 
reaction shows high transcript expression of Oct-3/4, nearly equal to housekeeping 
gene, Gapdh. (C) Top Panel: Western blot detection of Oct-3/4 in AB2.2 and Bottom 
Panel: E14 mESC. β-Actin loading controls shown below.  Negative indicates 
untransfected mESC, FAM, siOct-A, siOct-B are as described, collected 24 hours 
post-transfection of siRNAs, 4 hours post-seeding.   
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b. Oct-3/4, Sox-2 Knockdown and Differentiation into Trophectoderm 
 
We expanded upon these initial observations by measuring transcript and protein 
knockdown at 12 and 24 hour time points for Oct-3/4, in addition to Sox-2, using 
qRT-PCR and Western blot.  Following transfection with siRNAs cognate to Oct-3/4 
(siOct) or Sox-2 (siSox), significant decreases in both transcripts occurred in as little 
as 12 hours post-transfection as determined by qRT-PCR (Figure 11A).  Decreases in 
Oct-3/4 were approximately 80-90% across both cognate designs, whereas Sox-2 
levels decreased 40-55% across three cognate designs compared to FAM labelled 
negative controls.  Western blot measurements at 12 and 24 hours confirmed 
significant knockdown of both transcription factors (Figure 11B).  Embryonic stem 
cells transfected with FAM-labelled negative control retained a normal mESC 
morphology 6 days post-transfection, while siOct or siSox transfected cells 
differentiated into cells with the extensive cytoplasmic spreading and swollen nuclei 
characteristic of trophectoderm trophoblast cells, cells which were not visible in 
control conditions (Figure 12A and 12B). This finding is consistent with observations 
following forced abrogation of Oct-3/4 and Sox-2 expression (Niwa et al., 2000; 
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Figure 11. Knockdown of Oct-3/4 and Sox-2 using siRNA. (A) Top Panel: 
Quantitative real-time PCR detection of Oct-3/4 Bottom Panel: Sox-2 detection.  
Units are relative to endogenous Gapdh levels. Statistical significance (p < 0.05) as 
indicated by * when condition is compared to respective FAM control results and are 
representative of 3 independent experiments.  (B) Top Panel: Western blot detection 
of Oct-3/4 at 12 and 24 hr post-transfection. Bottom Panel:  Western blot analyses of 
Sox-2 expression at 12 and 24 hr post-transfection. Controls (FAM oligos, mock 
































Figure 12. Trophectodermal differentiation following Oct-3/4 or Sox-2 
knockdown (A) 10x and (B) 50x magnification.  Black arrows indicate examples of 
cytoplasmic spreading, swollen nuclei characteristic of trophectodermal derivatives 
which were visible in siOct and siSox transfected cells and absent in control samples 










4. Generation of Inducible Tet-Repressor (Tet-R) Short Hairpin RNA (shRNA)  
mESC  
 
a. Stable Transfection of Tet-R Protein into mESC  
 
Currently, abrogation of Oct-3/4 or Sox-2 expression can be achieved through a 
variety of means including siRNA and anti-sense oligonucleotides, among others. 
Except for the tetracycline regulatable Oct-3/4 ZbhTc4 and ZbhTc6 cell lines first 
reported by Niwa, et al (2000), no other regulatable Oct-3/4 or Sox-2 mESC lines 
have been reported.  Such lines would provide an important tool for the understanding 
of mESC transcription factors for they allow convenient quantitative and kinetic 
studies, without the potential perturbations caused by transfection or other nucleic 
acid delivery methods.  The aforementioned ZbhTc4 and ZbhTc6 cell lines have 
greatly furthered our understanding of the way the Oct-3/4 transcription factor 
maintains stem cell identity.  This includes identification of trophectoderm 
differentiation following forced cessation of expression, endodermal differentiation 
following upregulation, identification of SDIA dependency on Oct-3/4 expression, 
and complementation experiments which have elucidated the roles of various Oct-3/4 
fragments in transactivation (Niwa et al., 2002; Niwa et al., 2000; Shimozaki et al., 
2003).  However, it should be noted that while Oct-3/4 is a key molecule for ES cell 
identity, recent reports of co-regulation by Sox-2 and Nanog have suggested similarly 
important roles for pluripotency (Mitsui et al., 2003; Nichols et al., 1998; Okumura-
Nakanishi et al., 2005; Tomioka et al., 2002).  The generation of ZbhTc4/ZbhTc6, 
requiring homologous recombination of either one or both (respectively) alleles of the 
Oct-3/4 gene with a Tc-regulatable cassette, would require significant effort to 
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engineer and fail to provide a convenient model for extensibility to other important 
mESC factors including FoxD3, Stat-3, among others (Cavaleri and Scholer, 2003).   
 
Recent establishment of Tc-inducible RNAi based knockdown systems may provide a 
suitable replacement for engineering via homologous recombination.  These systems, 
requiring the initial stable expression of a tetracycline repressor (Tet-R) protein and 
subsequent engineering of short, hairpin vectors under the control of Tet-R, have the 
advantage of being easily created for the specific gene of interest.  We selected the 
Invitrogen BlockIT Tet-inducible RNAi system for our studies (Illustration 1).  While 
not permissive for over-expression studies, certain questions could be more easily 
addressed including establishment of a kinetic Oct-Sox-Nanog expression and 
transactivation profile following selection abrogation of any one of these three 
molecules.   Such a profile may help elucidate the underlying differences between the 
roles of Oct-Sox-Nanog and the combinations of these factors in the maintenance of 
pluripotency.  As such, they may also elucidate the underlying “combinatorial code” 
specified by transactivation targets, resulting in the varying cell type derivatives 


















Illustration 1. Invitrogen BlockIT tetracycline inducible short, hairpin RNA 
system. (A) pLenti6/TR can be transfected and packaged in ECO-PAK cells. (B) 
Alternatively, pcDNA6/TR can be utilized for direct plasmid transfection into mESC. 
(C) Constructed H1/TO entry vector can be directly transfected for transcript 
knockdown or can be transfected into TR expressing mESC for inducible knockdown 
studies. (D) TR protein typically binds to the H1/TO promoter, repressing any 
subsequent expression.  In the presence of tetracycline, TR protein does not bind to 
H1/TO and transcription occurs.  Transcription, in this case, is of an shRNA which 
proceeds to knockdown the cognate transcript via RNAi.   
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i. pLenti6/TR Lentiviral Propagation and Packaging 
 
Delivery of Tet-R protein can be achieved utilizing Lentiviral delivery.  Lentiviral 
delivery may be particularly advantageous as mESC can be difficult to transfect and 
may be extendable to similar lines such as hESC.  Plasmid encoding Lentiviral vector 
pLenti6/TR was propagated using E. coli, and digested with HindIII and BglII to 
ensure proper restriction mapping (Figure 13) as the long terminal repeats encoding 
the viral backbone are prone to recombination in prokaryotic systems such as E. coli 
(Dr. Michaeline Bunting, Invitrogen, personal communication). Such recombination 
would prevent proper packaging upon subsequent transduction into eukaryotic cells, 
although we did not observe here any recombination among various clones screened 
using restriction mapping.       
 
One clone (clone 1) was further propagated and subsequently transfected into the 
packaging cell line, ECO-PAK, a HEK-293 derivative commonly used for efficient 
viral packaging.  A control plasmid, GFP-C2 was separately transfected to ensure 
proper transfection as well as to observe proper downstream antibiotic selection as 
pLenti6/TR encodes Blasticidin resistance as opposed to the neomycin resistance 
encoded within GFP-C2.  Syncatia were observed in pLenti6/TR transfected cells, a 
morphological phenomenon observed with successful viral packaging (Figure 14).  
Blasticidin antibiotic selection, applied 48 hours after transfection, completely 
eliminated GFP-C2 transfected control cells within 7 days of application, leaving 
viable colonies of ECO-PAK colonies, which could be expanded for an additional 
week (Figure 14).  Viral supernatants from stable ECO-PAK packaging pLenti6/TR 
(ECO-PAK/TR) were collected and subsequently transduced into either E14 or AB2.2 
mESC.  However, it was subsequently observed that despite apparently successful 
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packaging in ECO-PAK/TR, mESC transduced with viral supernatant failed to 
survive Blasticidin selection.  A kill curve analysis was performed to determine the 
optimal concentration of Blasticidin necessary to completely eliminate untransfected 
mESC cells following 1 week of application (Figure 15).  Further attempts were made 
to alter passaging densities and selection time following transduction, without 












Figure 13. Tetracycline repressor (Tet-R) Lentiviral plasmid propagation. Vector 
pLenti6/TR was propagated in Invitrogen OneShot competent cells and multiple 
clones (clones 1-10 as designated) were restriction mapped using Hind III and Bgl II 
to insure correct propagation.  Clone 1, as designated, was restriction mapped and 
utilized for further experiments  
Observed: 3500, 600, 400 bp
 
Expected:3344, 3126,  
584, 556, 353, 4  
Observed: 4500, 3500 bp 
 
Expected: 4592, 3656, 66, 41 
Bgl II digest Hind III digest 









































Figure 14. Tetracycline repressor (Tet-R) Lentiviral packaging and selection in 
ECO-Pak cells.  pLenti6/TR transfected into HEK-293 derivative ECO-PAK cell line 
demonstrated syncatia characteristic of viral packaging.  GFP-C2 transfected cells 
served as selection controls. While 9 days of Blasticidin selection (applied 48 hours 
post-transfection) is sufficient to eliminate controls cells, pLenti6/TR transfected 
ECO-PAK (ECO-PAK/TR) cells survived, with expansion of cells occurring by day 
9.  However, despite this apparent success in viral packaging, supernatants collected 
from ECO-PAK/TR failed to transform mESC as the latter were unable to survive 













2 µg / mL 4 µg / mL 
















































Figure 15. Antibiotic selection of mESC – kill curve analysis. Kill curve analysis 
demonstrated for (A) Blasticidin and (B) Zeocin that E14 and AB2.2 could not 
survive in 4 µg/mL Blasticidin concentration, while E14 did not survive in 250 µg/mL 
Zeocin selection and AB2.2 in any concentration of Zeocin tested.  Blasticidin and 
Zeocin were further used at 5 µg/mL and 500 µg/mL concentrations, respectively. 
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ii. pcDNA6/TR Plasmid 
 
An alternative to utilizing pLenti6/TR as the delivery mechanism was to utilize the 
pcDNA6/TR plasmid for proper expression of Tet-R.  Plasmids pcDNA6/TR and 
GFP-C2 were separately transfected into mESC, with the latter again serving as a 
transfection and selection control.  Blasticidin selection was applied 48 hours post-
transfection and five days of selection were sufficient to achieve complete elimination 
of GFP-C2 negative control cells.  Mouse embryonic stem cells transfected with 
pcDNA6/TR and surviving Blasticidin selection were verified for proper expression 
of the Tet-R protein via RT-PCR and Western blot (Figure 16A and 16B).  Both 
methods confirmed proper Tet-R transcript and protein expression in AB2.2 (“AB2.2-
Tet A/B”) and E14 (“E14-Tet A/B”) cells, and mESC continued to appropriately 
express Oct-3/4 following Blasticidin selection (Figure 16B). 
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Figure 16.  Generation of Tet-R mESC lines, establishment of transient shRNA 
vector knockdown. (A) RT-PCR using primers specific for pcDNA6/TR plasmid 
amplified properly from multiple independent stably transfected cell lines (AB-
TetA/B or E14-TetA/B) grown in the presence of Blasticidin (5 µg/mL) and 
pcDNA6/TR positive control vector, but not undifferentiated mESC (E14 or AB2.2).  
(B) Tet-R protein was expressed in stable cell lines detected via Western blot using 
Tet-R-specific antibody (AB-TetA or E14-TetB) and Tet-R positive control peptide, 
but not undifferentiated mESC (E14 or AB2.2).  Oct-3/4 protein is expressed properly 
in undifferentiated mESC and stably transfected lines.  (C) Transient transfection of 
constructed shRNA plasmids are capable of Oct-3/4 knockdown with complete 
knockdown occurring 48 hours post-transfection for shOct1-4 and shOct2-2 vectors, 
but no knockdown is observed in GFP-C2 transfected controls (E14 shown).  
 
b. Generation of Tetracycline Inducible  Short, Hairpin RNA (shRNA) mESC Lines 
 
i. Construction and Design of shRNA Vectors 
 
AB2.2-Tet A/B and E14-Tet A/B cells properly expressing Tet-R required further 
manipulation in order to achieve inducible, specific knockdown.  Inducible Tet-R 
knockdown, technically a “Tet-On” system in which Tet-R represses the expression of 
a second vector encoding the transgene of interest, essentially behaves as a “Tet-off” 































































































































expression of a short, hairpin RNA.  This then processed and degrades the target gene 
of interest via RNAi.  Using validated siRNA target sequences described in earlier 
sections, the design of the shRNA vectors was initiated to include the generation of 
H1/TO entry vectors within target gene sequence, variable hairpin designs, as well as 
an inverted repeat.  Previously linearized vectors were ligated to pre-annealed duplex 
long oligos (~60 bp), propagated and their sequences verified.   
 
It was observed that a significant number of clones, while containing the proper 
inserted duplexed oligo of interest, featured sequence errors including deletions, 
insertions, or mismatches.  This observation is consistent with previous reports (Dr. 
Michaeline Bunting, Invitrogen, personal communication) and is of unknown origin 
although one possibility is that it is due to poor purification of synthesized long 
oligonucleotides.  Coupling efficiency, despite routinely being 99% per nucleotide, 
may result in larger numbers of improper sequences with length of the 
oligonucleotide.  The annealing of two long oligonucleotides would further increase 
the probability of improper sequence generation, although this can not entirely 
account for the extremely few numbers of correct sequence clones identified (1 out of 
20).  Supplier error appeared to be unlikely as identical sets of oligonucleotides from 
two vendors resulted in similar numbers of clones containing errors.         
 
ii. Stable Transfection and Selection into mESC  
 
Despite the number of clones observed with incorrect sequences, such sequences are 
still capable of efficient RNAi depending on the location and extent of the mismatch.  
Mismatches near the 5’ antisense end of siRNAs can be as large as 5 bp without 
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perturbing efficient knockdown, while even 1-3 mismatches near the 3’ antisense can 
completely eliminate knockdown capability (Dr. Michaeline Bunting, Invitrogen, 
personal communication).   Short, hairpin vectors specific for Oct-3/4 were 
transfected into mESC and probed by Western blotting to determine knockdown 
efficiency.  It was observed that transient knockdown could be achieved using shRNA 
vectors despite mismatches when transfected into undifferentiated mESC (Figure 
16C).  One observation was that while siRNA-based knockdown was capable of 
degrading Oct-3/4 transcripts and reduce protein expression in as little as 12 hours, 
nearly 48 hours was necessary to observe protein knockdown using shRNA vectors 
(Figure 16C).  This is presumably due to the time required for shRNA expression or 
the shRNA maturation into siRNA-like intracellular molecules following hairpin 
cleavage (Hammond, 2005).  
 
Following the establishment of transient shRNA knockdown for our vector constructs, 
mESC expressing Tet-R were transfected with Oct-3/4 shRNA vector and placed 
under Zeocin selection, 48 hours post-transfection. After approximately 1 week, 
virtually all GFP-C2 cells had been eliminated and expansion of shRNA transfected 
colonies was observed.  Following an additional 1-2 weeks of expansion, stable 
mESC were stored as frozen stocks.  Cells were continuously cultured in the presence 
of both Blasticidin and Zeocin antibiotics to ensure the positive selection of Tet-R and 
shRNA cassettes, respectively.  Stable cell lines expressing TetR (for naming 
convention, see Materials and Methods) and containing H1/TO Oct-3/4 hairpin 
cassettes grown continuously in selection media containing Blasticidin and Zeocin 
showed normal round, mESC cell morphology (Figure 17), while untransfected 
mESC failed to proliferate in selection media with either antibiotic. Furthermore, 
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unaltered expression of relevant expression markers including Oct-3/4, Sox-2, Nanog, 








Figure 17. Morphology of stably transfected mESC. mESC, stably transfected with 
Tet-R and H1/TO vectors were selected using Blasticidin and Zeocin respectively, 
maintained a normal morphology when grown in the presence of both antibiotics (5 
µg/mL Blasticidin, 500 µg/mL Zeocin) 


















































Figure 18. Characterization of pluripotent markers (Oct-3/4, Sox-2, Nanog, 
SSEA-1) in stably transfected mESC. The mESC lines were transfected with 
inducible shRNA. Expressions of multiple pluripotent mESC markers (Oct-3/4, Sox-
2, Nanog, and SSEA-1) were determined by flow cytometry after stable serial 
transfections with Tet-R and Oct-3/4 cognate shRNA vectors (O1-4 and O2-2).  
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Stable cell lines, when analyzed by Western blotting for Oct-3/4, showed highly 
efficient knockdown (Figure 19).  Successful inducible shRNA were reproducibly 
performed in 2 independent experiments within the first 5-6 passages (~2-3 weeks) of 
expansion following selection. However, no significant knockdown was observed in 
these cells when cultured for more than 8 passages (~3-4 weeks).  This lack of 
knockdown after prolonged culture may be related to gene silencing.        
 
Gene silencing is a common problem for establish stable expression systems in 
mESC.  The CMV promoter, as well as other viral promoters, express poorly in 
mESC and are prone to silencing (Suter et al., 2006), although in this experiment, 
silencing of the CMV promoter led to Tet-R protein ablation, induced expression of 
shRNA and then target destruction as opposed to maintenance.  A likely scenario also 
is the silencing of the shRNA promoter, H1/TO, as silencing would prevent target 
gene destruction, even though this promoter and similar RNA polymerase promoters 











Figure 19. Inducible shRNA knockdown of Oct-3/4. Inducible knockdown of Oct-
3/4 was observed when Tc was added to the culture medium for a period of 3 days.  β-





























5. Differentiation of mESC following Oct-3/4 and Sox-2 knockdown  
 
a. SDIA Differentiation Following Oct-3/4 and Sox-2 Knockdown  
 
While many studies of Oct-3/4 and Sox-2 have largely focused on the maintenance 
role of factors in maintaining pluripotent stem cell identity (Chambers, 2004; Nichols 
et al., 1998), there is evidence for a role for both transcription factors in neurogenesis.  
It has been recently demonstrated that abolishment of Oct-3/4 leads to retardation of 
neurogenesis in PA6 stromal-derived inducing activity (SDIA) from mouse 
embryonic stem cells (mESC) engineered with a tetracycline (Tc) regulated Oct-3/4 
cassette (Kawasaki et al., 2000; Shimozaki et al., 2003).  Similarly, early 
neuroectodermal progenitors cells express Sox-2, and it has been reported that 
overexpression leads to differentiation into neuroectodermal derivatives (Sasai, 2001; 
Zhao et al., 2004).  Given the apparent inability of our stably transfected Tet inducible 
mESC to silence reproducibly, we next studied mESC differentiation following 
transient siRNA knockdown.    
 
i. Establishment of Precise Transcript Quantification Using Cloned Standards 
 
A panel of qRT-PCR primers and plasmid standards for Oct-3/4 and Sox-2, their 
canonical transactivation targets (Utf-1, Fbx-15, Fgf-4, Opn), and germ-layer specific 
lineage markers (neuroectodermal Nestin, dopaminergic neuron-specific Ptx-3, 
mesodermal Brachyury, and endodermal Gata-4) was developed.  Two to three primer 
pairs per gene ranging in length from 80-180 base pairs were designed and screened 
based on high efficiency and wide dynamic range of detection (Table 1).  We 























































































hours post-transfection siOct and siSox transfected mESC cDNAs, we could amplify 
and isolate all the genes of interest with the exception of Brachyury, which was 
amplified and subsequently subcloned from cDNA prepared from foetal murine heart 
(Figure 20).  Plasmids containing the inserts of interest were subsequently linearized 
using XmnI or SacII, and diluted from 108-104 copies per reaction to evaluate the 
efficiency, dynamic range of quantification and specificity of the assays (Figures 21A 
















Figure 20. Cloning of Oct-Sox transactivation targets and lineage-specific 
markers. Real-time PCR standards were cloned from a mixed pool of cDNA 
including endodermal markers (Gata-4), mESC pluripotent markers (Nanog, Sox-2), 
neural markers (Nestin, Ptx-3, Nurr1), among others.  Mixed cDNAs were composed 
of undifferentiated, 12 and 24 hours siOct or siSox siRNAs post-transfected mESC 
cDNAs. A DNA marker was co-electrophoresed with the samples.
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Table 1. Selection of Real-Time PCR primer sets.  
 












 (-slope of Ct v. copy 
number) 
No Template Control 
Amplification (Ct) 
    
Oct-3/4  297 – 378 4.55 19.4 
Oct-3/4  573 – 677 2.98 33.9 
Oct-3/4  1056 - 1153 3.68 28.2 
Sox-2  71 - 230 3.49 36.7  
Sox-2  1182 - 1345 4.36 34.3  
    
Fgf-4  552 - 633 3.3  N/A  
Utf-1  382 - 644 Poor Amplification 22.9  
Utf-1  865 - 1063 4.07 28.1  
Fbx-15  214 - 305 3.20 33.8 
Fbx-15  866 - 951 3.40 25.3 
Opn  600 - 682 3.70 33.5  
Opn  880 - 969 3.76 29.2  
    
Nestin  1162 - 1305 3.60 32.8  
Nestin  3504 - 3602 3.62 29.25  
Ptx-3  139 - 226 3.99 30.7  
Ptx-3  207 - 313 4.34 30.8 
Ptx-3  450 - 559 4.78 35.8  
Brachyury  1113 - 1308 3.68 27.2 
Brachyury  1637 - 1832 3.26 29.1 
Gata-4  1559 - 1665 3.4 28.3 
Gata-4  399 - 592   3.4 30.8 
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Nestin 1162 / 1305  









0 2 4 6 8 10
B 
108  107 NTC 104  105106  
A 






































Figure 21. Specific and efficient qRT-PCR detection of Oct-Sox transactivation 
targets, lineage-specific markers. (A) Standards were screened for efficiency as 
determined using 10 fold serial dilutions ranging from 108-104 copies per reaction and 
appearance of primer dimers in NTC, non-template controls.  (B) Standard curve 
equation from displayed amplification curve for Nestin 1162-1305 primer set. The 
slope of the curve was determined to be -3.59 (equivalent to greater than 90% 
amplification efficiency).         
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ii. Quantification of Oct-3/4, Sox-2, Canonical Transactivation Targets Following 
Knockdown  
 
While several studies have examined the characteristics of Oct- and Sox- binding 
elements within canonical Oct-Sox target promoters (Ambrosetti et al., 1997; Botquin 
et al., 1998; Okuda et al., 1998), the relative quantitative and temporal expression 
changes of these genes as a result of RNAi knockdown in mESC is largely unknown.  
Transactivation of canonical Oct-3/4 and Sox-2 targets including Utf-1, Opn, and 
Fbx-15 was largely unperturbed 24 hours following transfection of siOct or siSox, 
with the exception of Fgf-4, which showed a 50-60% decrease of transcript 
expression levels compared to FAM negative control following Oct-3/4, but not Sox-2 
cognate siRNA transfection (Figure 22 and 23, respectively).  These results are 
largely consistent with observations that Tc regulatable Oct-3/4 mESC maintain 
expression levels of Oct-3/4 transactivation targets for at least 24-72 hours following 
cessation of Oct-3/4 expression (Niwa et al., 2000) and together these results suggests 
the core cooperative transcriptional machinery of Oct-3/4 and Sox-2 is largely 












































Figure 22. Characterization of canonical transactivation targets following Oct-
3/4 knockdown. Quantitative real time PCR transcript detection of canonical Oct-Sox 
targets as indicated, 12 and 24 hrs post-transfection of Oct-3/4 cognate siRNAs.  Fgf-
4 showed a minor decrease 24 hours after transfection.  Statistical significance (p < 
0.05) as indicated by * when condition is compared to respective FAM control. 
Statistical significance (p < 0.05) as indicated by * when condition is compared to 
respective FAM control and are representative of three independent experiments.   
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Figure 23. Characterization of canonical transactivation targets following Sox-2 
siRNA knockdown. Quantitative real time PCR transcript detection of canonical Oct-
Sox targets as indicated, 12 and 24 hrs post-transfection of Sox-2 cognate siRNAs. No 
significant changes were observed in various canonical Oct-Sox targets. Statistical 
significance (p < 0.05) as indicated by * when condition is compared to respective 
FAM control and are representative of three independent experiments.   
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b. Screening for Alternative Cellular Fates  
 
i. Transcript Quantification of Lineage Specific Markers  
 
Following the successful knockdown of Oct-3/4 and Sox-2, mESC were then placed 
onto neural-inducing PA6 cells 24 hours post-transfection.  A reduction in neuron-
specific TuJ1+ was observed (Figure 24).  Colony counts of TuJ1+ colonies indicated 
a significant decrease following transfection of siOct, and to a lesser extent, siSox, 
sequences (Figure 25).   
 
It was observed that 45%±12, 65%±13 and 90%±8 of the colonies were stained with 
neuron-specific TuJ1 across siOct, siSox, and FAM negative control siRNAs 
transfected mESC respectively, with the reduction in neurogenesis consistently 



























Figure 24.  Attenuation of neurogenesis following Oct-3/4, Sox-2 siRNA 
knockdown in PA6 SDIA co-cultures. Neural differentiation of E14 mESC on PA6 
co-cultures seeded 12 hours following FAM siRNA negative control, siOct-B, and 
siSox-A transfections as indicated.  Tuj1 staining was reduced in differentiating 
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Figure 25.  Colony counts of PA6 SDIA co-cultures following Oct-3/4, Sox-2 
siRNA knockdown. Significantly lower neurogenesis, as measured by neuron-
specific TuJ1 staining, was observed in mESC transfected with Oct-3/4 or Sox-2 
cognate siRNA sequences and seeded on PA6 co-cultures. Value is described as a 
percentage of total number of colonies counted (N>35). Statistical significance (p < 
0.05) as indicated by * when condition is compared to respective FAM control and 
results are representative of two independent experiments.   
 
 
Extending our observations of SDIA in PA6 co-cultures, we utilized a Hep-NIF SDIA 
Neurogenesis model (Yamazoe et al., 2005).  Neuronal differentiation was similarly 
reduced in mESC transfected with Oct-3/4 or Sox-2 cognate siRNAs using neuron-
specific TuJ1 staining (Figure 26A).  It was observed that in Hep-NIF SDIA, cells 
transfected with either siOct or siSox had a significant population of TuJ1- cells 
which bore resemblance to neither trophectoderm trophoblast cells, expected from 
Oct-3/4 or Sox-2 knockdown, nor extensive neurite formation.  Under bright field 
microscopy, TuJ1+ colonies show a bright, cluster morphology, while these cells had 



























































Figure 26.  Attenuation of neurogenesis following Oct-3/4, Sox-2 siRNA 
knockdown in PA6 SDIA co-cultures and Heparin feeder-free SDIA. (A) Tuj1 
staining was reduced in Hep-NIF SDIA differentiated siOct and siSox transfected 











One advantage of using Hep-NIF SDIA is that the contribution from the PA6 feeder is 
minimized when analyzed by qRT-PCR. Increases in Nestin expression following 
siOct and siSox transfection were observed, but they were not statistically significant, 
and they were only seen with one of the cognate Oct-3/4 siRNA design (Figure 27).  
 
The dopaminergic neuron-specific marker Ptx-3 decreased 60% and 20-50% 
following siOct and siSox transfection, respectively (Figure 27).  Expression of 
mesodermal (Brachyury) and endodermal (Gata-4) markers was present in SDIA 
differentiated cells, presumably due to spontaneous differentiation under SDIA 
conditions, but expression of neither Brachyury nor Gata-4 significantly increased 
following siOct or siSox transfection compared to FAM-labelled negative controls 
(Figure 27).  This suggests that these mESC did not differentiate into cellular fates 































































































Figure 27. Detection of lineage-specific markers. Profiling of lineage specific 
markers as indicated.  Values are reported using ∆∆Ct calculations calibrated against 
FAM labelled negative control.  Statistical significance (p < 0.05) as indicated by * 
when condition is compared to respective FAM control and results are representative 
of three independent experiments.   
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ii. Appearance of Glial-Like cells during SDIA induced differentiation  
 
In an attempt to further characterize differentiated cells following Oct-3/4 and Sox-2 
knockdown and SDIA-induced neurogenesis, we screened for several neural markers 
using immunocytochemistry, including neural progenitor CD-133/Prominin, 
oligodendrocyte O4 marker, and glial cell GFAP markers (Kania et al., 2005; Liu et 
al., 2002; Uchida et al., 2000).  The maintenance of Nestin expression suggested the 
derivative cells were still of a neuroectodermal phenotype, but potentially channelled 
into non-neuronal, or alternative neuron fates due to the loss of dopaminergic Ptx-3 
transcript expression.   The lack of increase in mesodermal Brachyury or endodermal 
Gata-4 expression did not support the argument that these cells had been 
differentiated into alternative germ layers.   
 
While SDIA-differentiated mESC did not express CD-133/Prominin or O4 markers 
for neural progenitors or oligodendrocytes respectively, we did observe positive 
staining for GFAP across control SDIA-differentiated, Oct-3/4, and Sox-2 knockdown 
conditions.  It was observed that the dark, discrete cells observed following Oct-3/4 
and Sox-2 knockdown SDIA-neurogenesis stained positive for GFAP, but not neuron-
specific TuJ1 (Figure 28).  Furthermore, SDIA has been described primarily as a 
neurogenesis condition resulting in the formation of neuron-like cells, and not 
resulting in significant gliogenesis in PA6 co-cultures.  It has not been reported if 
Hep-NIF SDIA results in differentiation of GFAP+ cells, and it is possible that this 
method results in significant gliogenesis as only 30-50% of colonies are TuJ1+. We 
did observe that TuJ1+ colonies contained a significant number of GFAP+ cells, 
which appeared to be growing beneath them (Figure 29).  Expression of GFAP was 
 60
confirmed by immunoblotting; for further characterization of a glial-like cell 
derivative we also confirmed the expression of a related glial cell lineage marker, 
Vimentin; neither Vimentin nor GFAP can be detected in undifferentiated mESC 
(Figure 29).  
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Figure 28. GFAP and TuJ1 expressions in SDIA cultures.  (Colonies previously 
unstained for TuJ1 (red) composed of dark discrete cells stained for GFAP (green).  












Figure 29. GFAP and Vimentin expressions in SDIA cultures.  (A) It was 
observed that TuJ1+/GFAP+ differentiating neurospheres had a layer of GFAP cells 
which appeared to lie below TuJ1+ cells.  (B) Western blot of glial markers, GFAP 
and Vimentin, for undifferentiated mESC (E14 or AB2.2), FAM, siOct-A/B, siSox-
A/B/C transfected SDIA differentiated cells as indicated.  No GFAP or Vimentin was 
detected in undifferentiated mESC, but was highly expressed in SDIA differentiated 



































Discussion and Future Work 
 
Following established methods for the culturing pluripotent mESC, we have 
differentiated these naïve cells into neuron-like cells using PA6 co-cultures and Hep-
NIF SDIA.  Such cells stain positive for several markers, including NF-L, TH, TuJ1 
as well as Nestin and the dopaminergic marker Ptx-3 transcripts.  We have observed 
that the process of SDIA neurogenesis largely supports the idea of an an instructive 
model of development.  Under differentiating conditions, including serum withdrawal, 
SDIA is necessary for efficient neurogenesis as PBS control addition without heparin-
NIF SDIA failed to yield neuron-like cells.  Maintenance conditions for mESC 
include serum, which has been shown to function equivalently to a cocktail of 
Transforming Growth Factor superfamily-related factors, including the BMPs (Ying 
et al., 2003).  Therefore, it can be concluded that removal of these factors via serum 
withdrawal is not sufficient for the predisposition of mESC into neuron-like fate, but 
that additional factors such as SDIA are necessary for neuronal differentiation.  The 
molecular identity of SDIA still remains unknown, nevertheless the apparent 
instructive nature of SDIA may aid future studies seeking to decipher its identity.  
Among instructive factors, the FGFs, and especially the striking similarity of 
exogenous Fgf-8’s ability (in combination with Sonic Hedgehog) to differentiate 
mESC into TH+/TuJ1+ colonies is one of the possibilities (Roussa and Krieglstein, 
2004; Sasai, 2002).      
 
Using the Hep-NIF SDIA model, we have observed the differentiation of glial-like 
cells expressing GFAP and Vimentin from mESC (Liu et al., 2002).  This is 
surprising given the reported role of SDIA in inducing neurogenesis.  Original reports 
of PA6 co-cultures reported <5% of colonies were GFAP+ (Kawasaki et al., 2000), 
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however, it should be noted that while PA6 co-cultures differentiate 80-90% of mESC 
colonies into neuron-specific TuJ1+ neurospheres, Hep-NIF SDIA results in only 30-
50% efficiency (Yamazoe et al., 2005).  The characterization of the alternative cell 
types generated by Hep-NIF SDIA was not reported by Yamazoe et al., (2003).   
 
Given the significant population of colonies that are TuJ1- (50-70%) that result from 
Hep-NIF SDIA, it is entirely possible that significant glial-like cell populations are 
generated as a result of this method and were not detected by Yamazoe and 
colleagues.  Indeed, very recent reports have emerged supporting a SDIA model of 
gliogenesis, as neural progenitor cells differentiated by PA6 co-culturing resulted in 
significant glial-like cellular differentiation, but most surprisingly, few neuron-like 
cellular derivatives (Kitajima et al., 2005; Roybon et al., 2005).   It has been further 
suggested that SDIA possesses dual early- and late-stage differentiation capability, 
therefore accounting for the apparent discrepancy between progenitor and mESC 
SDIA differentiation.  However, SDIA neurogenesis of mESC has been shown to 
result in progenitor-like intermediaries, given the apparent plasticity demonstrated by 
the channelling into other neuronal fates following supplementation with other factors 
(Mizuseki et al., 2003).  Therefore, both the results of this work and emerging reports 
suggest that SDIA is capable of triggering both gliogenesis and neurogenesis.  The 
former is of major significance given novelty, ease of differentiating mESC into glial-
like cells in comparison to established gliogenesis methods, and potential therapeutic 
value (Brustle et al., 1999; Liour and Yu, 2003).       
 
However, the results of this study are not conclusive of Oct-3/4 and Sox-2 channelling 
SDIA differentiation into glial-like cells, as these cells are observed even in control 
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Hep-NIF SDIA conditions.  Furthermore, the glial cell markers GFAP and Vimentin 
do not appear to be significantly enhanced following Oct-3/4 or Sox-2 knockdown 
coupled with SDIA differentiation (Figure 28C).   
 
Nevertheless, this does not make the suggestion of a role for Oct-3/4 and Sox-2 in 
gliogenesis to be irrelevant, given the relative population sizes in consideration.  If 
50-70% of Hep-NIF SDIA differentiated cells are already glial-like 
GFAP+/Vimentin+ cells, Oct-3/4 or Sox-2 enhancement would be limited to a 
maximal 30-50% enhancement differential, which may be too small for significant 
qRT-PCR or Western blot detection.  Furthermore, suggestions for a role for Oct-3/4 
in gliogenesis are further supported by a report that neuronal/glial fate switching 
factor, Prp 19, was involved in induction of Oct-3/4 expression; the induction of Oct-
3/4 expression via Prp19 resulted in neurogenesis whereas removal of this induction 
resulted in gliogenesis (Urano et al., 2006).  The latter observation is highly 
concordant with the results of this study, as decreases in Oct-3/4 in neurogenesis 
conditions results in gliogenesis in both studies.   
 
While Oct-3/4 and Sox-2 have traditionally been utilized as markers for 
characterizing pluripotent mESC, more recent reports have detailed the role of both 
transcription factors in cell fate determination, particularly neuroectoderm formation.  
Using a PA6 model of neurogenesis, tetracycline-induced abolishment of Oct-3/4 up 
to four days markedly decreases the number of MAP2+ colonies (Shimozaki et al., 
2003).  The overexpression of Sox-2 does not interfere with mESC self-renewal in 
pluripotent maintenance conditions, although similarly to Oct-3/4, constitutive 
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expression in a serum-free differentiation condition enhances neurogenesis (Zhao et 
al., 2004).    
 
Unlike the study of Shimozaki, et al. (2003), in which Oct-3/4 expression was 
abrogated from the beginning, our study features the knockdown of Oct-3/4, at the 
earliest, one day into differentiation.  Furthermore, Shimozaki, et al. utilized a 
tetracycline-regulatable Oct-3/4 cassette to maintain abrogation of Oct-3/4 expression 
throughout the course of differentiation, so suppressing any subsequent expression of 
Oct-3/4 protein, while our study features a transient knockdown of Oct-3/4 which 
may or may not suppress later elevated expression levels.  Our results extend these 
observations by demonstrating an earlier knockdown (day 0 of differentiation) of Oct-
3/4 or Sox-2 similarly retards SDIA activity and even if such knockdown is transient, 
is sufficient to retard efficient neurogenesis.  Therefore, it is suggested any SDIA 
cueing of Oct-3/4 (or Sox-2) into a neurogenic pathway is a rapid and precisely timed 
early event in neurogenesis.    
 
By utilizing a specific siRNA knockdown approach our results extend observations 
for a role for Oct-3/4 in SDIA, including the implication of a similar role for the 
related factor, Sox-2.  Shimozaki and colleagues speculated that Oct-3/4 involvement 
in SDIA may be dependent on Sox-2, given the reported roles of both molecules in 
cooperative transactivation of each other (Okumura-Nakanishi et al., 2005; Tomioka 
et al., 2002).  In our study, the addition of instructive SDIA occurs at a time point (24 
hours) during which specific abolishment of either Oct-3/4 or Sox-2 alone is able to 
retard efficient SDIA.  If SDIA involving Oct-3/4 activity was entirely Sox-2 
independent, abolishment of Sox-2 would remain permissive of efficient SDIA as 
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Oct-3/4 transcripts are still detectable 24 hours post-transfection.  Conversely, this 
would also implicate SDIA activity involving Sox-2 to be dependent on Oct-3/4 as 
well due to the fact that specific Oct-3/4 destruction leaves Sox-2 detectable 
transcripts present at time of SDIA instruction.  Therefore, the results of this study 
suggest that any involvement of either transcription factor in SDIA is a requisite 
cooperative effect involving downstream neurogenesis targets which remain to be 
elucidated.   
 
A key observation is that differentiation occurs at a time point during which Oct-3/4 
or Sox-2 transcripts have been reduced via RNAi, but have not altered downstream 
targets such as Utf-1, Fbx-15, Fgf-4 and Opn.  While Oct-3/4 and Sox-2 cooperative 
transactivation of these have been studied using promoter-reporter constructs, they are 
often studied in alternate cell types such as HeLa (Nishimoto et al., 1999), 3T3 
(Tokuzawa et al., 2003), among others, which may not properly express co-factors or 
additional mechanisms regulating these genes.  The results of this study suggest 
transactivation targets to be fairly robust following Oct-3/4 or Sox-2 transcript 
reduction.   
 
Whereas Oct-3/4 or Sox-2 knockdown over a 6-day time course results in 
trophectoderm differentiation in mESC maintenance conditions (Carpenter and 
Zernicka-Goetz, 2004; Hay et al., 2004; Velkey and O'Shea, 2003), addition of 
neuronal-differentiating SDIA 24 hours after Oct-3/4 or Sox-2 knockdown results in a 
cellular phenotype resembling neither neuron-like cells nor trophectoderm.  This 
study suggests these are glial-like cells expressing GFAP and Vimentin, although this 
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is not conclusive given the potential of Hep-NIF SDIA to be a gliogenesis method as 
well as the quantitative limitations described above.   
 
Nevertheless, this hypothesis is consistent with observations using qRT-PCR lineage 
screening that demonstrate a reduction in dopaminergic neuron-specific Ptx-3 
expression following siOct or siSox transfection.  This is concomitant with a 
reduction in the number of TuJ1+ colonies, demonstrating a reduction in neuron-like 
derivatives.  Lack of increase in other lineage markers such as mesodermal Brachyury 
and endodermal Gata-4 suggest they are still of neuroectodermal lineage (Wiese et at., 
2004) and this is supported by evidence of the continual expression of Nestin 
transcript.  Nestin, an early neuroectodermal marker is conserved among glial, 
neuron, and oligodendrocyte derivatives.   
 
Future works could address four main issues.   The first issue of primary interest is the 
gliogenesis capacity of SDIA.  The default, or at least preferential, differentiation of 
mESC into neuron-like cells currently limits differentiation into other 
neuroectodermal cell types such as glia.  The potential of SDIA to generate significant 
populations of these cells may be particularly promising, given the relative ease with 
which they can be generated and their significant therapeutic potential.  It is of note 
that among the first potential cell-based therapies, glia are considered particularly 
promising as such transplanted cells may be useful for biochemical and biophysical 
maintenance of the brain, as opposed to the more intricate and elaborate biochemical 
neural networks that neuron-based therapies may require  (Brustle et al., 1999).  
Characterization of SDIA-derived cells using a panel of glia cell markers including S-
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100β and RC1 could be utilized in qRT-PCR and Western detection, before eventual 
purification and transplantation into animal models with neural damage.   
 
A secondary issue for consideration would be to further the inconclusive, but 
suggestive findings of the putative Oct-3/4 and Sox-2 gliogenesis roles. As described, 
previous works have reported Oct-3/4 transcript abrogation as resulting in 
trophectoderm under maintenance conditions and inhibiting neuron-like cell 
formation under SDIA neurogenesis conditions.  The establishment of Oct-3/4 
involvement in gliogenesis provides an additional cellular fate for consideration.  
Similarly, while Sox-2 enhances neuron-like cell formation in neurogenesis 
conditions, we have demonstrated Sox-2 abrogation in SDIA results in an inhibition 
of neurogenesis and the formation of glial-like cells. Given the ability of these factors 
to determine an expanding series of cellular fate choices, involvement in gliogenesis 
provides an additional comparative state to determine if the underlying transactivation 
targets account for the apparent versatility of these molecules in mESC cellular fate 
choices. Future studies using flow cytometry or purification methods may provide a 
means to quantify glial-like cellular derivatives and characterize such cells.  Such 
cells could be further analyzed using transcriptome profiling via microarrays or qRT-
PCR to identify those requisite transactivation profiles deterministic of their fate.  
 
Extending the above pursuits would focus on discriminating differences between Oct-
3/4 and Sox-2 in gliogenesis and neurogenesis conditions.   
While behaving similarly in this series of experiments, greater reductions in TuJ1+ 
colonies and Ptx-3 transcript levels were observed in differentiated mESC transfected 
with siOct in comparison to those transfected with siSox.  In addition, significant 
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decrease in expression of Fgf-4 was observed only following siOct transfection.  
Exploring the greater significance of these variations could further decipher the 
“combinatorial code” governing fate decisions in mESC.  However, establishing 
discrete roles for Oct-3/4 and Sox-2 is challenging as synergistic effects between the 
two molecules are a significant obstacle to de-coupling roles for each.  Silencing both 
Oct-3/4 and Sox-2 in parallel and observing potential differences in comparison to 
individual silencing would allow some (albeit limited) discrimination between roles 
for Oct-3/4-Sox-2 complexes and individual molecules.  This approach could be 
similarly expanded using overexpression studies of Oct-3/4, Sox-2, or both in SDIA 
conditions which would provide a complimentary set of quantitative permutations for 
cell fate choices.   
 
Finally, future pursuits would warrant successful establishment of the inducible 
shRNA mESC lines, given their utility and extensibility.  Transcriptional silencing in 
mESC has been previously observed in a wide variety of contexts including 
transgenic animal generation.  The diversity of outputs resulting from promoter 
choice, such as ubiquitous expression with CAGGS promoters and comparatively 
poor success of viral based promoters may be informative for establishing robust 
expression systems in mESC.   However, while the CMV promoter was utilized in 
this study for Tet-R expression, the apparent failure to robustly silence (following the 
addition of Tc) this promoter does not suggest this to be problematic in our studies, as 
Tet-R silencing would actually result in target knockdown.  An alternative possibility 
is that while the H1 promoter has been reported to function in mESC without 
detriment (Velkey and O'Shea, 2003), it may not be a particularly strong promoter to 
achieve the desired knockdown results and could be substituted for alternative 
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choices.  It was recently reported that a significant improvement for the pLenti6 
plasmid used in this study could be achieved following addition of viral elements to 
significantly enhance high and homogenous transgene expression without silencing 
(Suter et al., 2006). Furthermore, a genuine “Tet-on” mESC expressing GFP could be 
a convenient means to insure proper function of the Tet-repressor inducible system, 
while recently developed qRT-PCR based shRNA detection techniques could further 
confirm proper cassette expression to eliminate sources of malfunction within a Tet 
inducible shRNA knockdown cell.  
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Materials and Methods  
 
Mouse Embryonic Stem Cell Culture  
 
Mouse embryonic stem cell (mESC) lines, E14 and AB2.2, were grown in high-
glucose ES cell media (Gibco) containing 15% FBS (Hyclone), 1x glutamine-pen-
strep (Gibco), 143 µM β-mercaptoethanol (Merck) and 103 U/mL LIF-ESGRO 
(Chemicon), passaged routinely 3 times per week with daily ES cell media 
replacement.  Embryoid bodies were generated by placing 106 mESC dissociated 
using trypsin into single cells onto 10 cm bacterial plates in ES cell media.  Alkaline 
Phosphatase detection was performed using Vector Labs kit (cat no. SK-5100).  
Staining of SSEA-1 was done following aspiration of media, 1x washing with 1% 
PBS/BSA, incubation with 4% paraformaldehyde for 30 minutes, 1-hour primary 
antibody incubation (1:80) and application of secondary antibody.  
 
Stromal-Derived Activity (SDIA) via PA6 Co-Cultures or Heparin Neural-Inducing 
Factors  
 
Stromal PA6 cells were cultured in Alpha medium (Gibco) containing 10% FBS 
(Hyclone) and 1x pen-strep (Gibco).  Stromal-derived inducing activity (SDIA) was 
performed as previously described using Glasgow medium (Gibco) (Kawasaki et al., 
2000).  
 
Feeder-free usage of SDIA collected from PA6 using heparin solutions was 
performed as follows.  Confluent T75 flasks of PA6 were washed three times with 10 
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mL PBS, incubated for 30 minutes and 37oC using 100 or 10 ug/mL heparin-PBS(+) 
solutions. Incubated solutions, were stored as frozen aliquots at -20oC and added as a 
1:2 ratio of NIFs:Differentiation Media to 0.1% gelatin coated 12-well dishes 
previously seeded overnight with 6,000 E14 or AB2.2 ES cells, 20-24 hours post-
transfection with siRNAs.  Cells were allowed to differentiate for a period of 8 days 
with seeding time counted as day 0.  
 
Immunocytochemistry of SDIA differentiated cells was performed using 1x PBS 
wash, 4% formaldehyde addition at room temperature for 30 minutes, followed by 1% 
PBS/BSA incubation for 30 minutes, addition of TuJ1 primary antibody (Chemicon, 
BAM1195) at 1:500 dilution with overnight incubation at 4 ˚C, 3x 1%PBS/BSA 
wash, secondary antibody (Molecular Probes A11029) addition at 1:1000 dilution,  
followed by 2x 1% PBS/BSA wash.  Cells were also stained for neuronal progenitor 
CD-133 (Santa Cruz, 23797) 1:50 dilution, mature oligodendrocyte O4 (Chemicon, 
MAB345) 1:80 dilution, Neurofilament Light Chain (Sigma, 5139) 1:500 dilution, 
dopaminergic marker Tyrosine Hydroxylase (Chemicon, MAB1423) 1:80 dilution, 
and glial GFAP (Sigma, G9269) 1:80 dilution. 
 
Establishment of Efficient Rapid Transfection Method  
 
Comparison of transfection reagents was done by seeding 8x104 mESC in 96-well 
plates coated overnight with 0.1% gelatin (in water) in a volume of 100 µl, and 
transfected using 3 picomoles FAM labelled oligo dT (21-mer) complexed in serum-
free Opti-Mem I with commercial reagents according to concentrations specified by 
the manufacturer (CaPO4 - 0.36 µl CaCl/ 3 µl HEPES-buffer solution, Oligofectamine  
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(Invitrogen) 0.25 – 1 µl,  Lipofectamine 2000 (Invitrogen) 0.1 - 0.4 µl, Transfectin 
(Bio-Rad) 0.1 - 0.6 µl , Fugene 6 (Roche) 0.15 - 0.3, Transpass (New England 
Biolabs) 0.5 - 2 µl.  Exgen (Fermentas) was complexed in 150 mM NaCl solution 
with a reagent volume of 0.8 - 1.15 µl as specified by manufacturer.   
 
Oct-3/4 or Sox-2 Knockdown Using Small Interfering RNAs  
 
For Oct-3/4 or Sox-2 knockdown, 2.5x105 E14 or AB2.2 cells were seeded per well in 
12-well plates previously coated overnight with 0.1% gelatin (in water) in 1 mL 
mESC media containing LIF-ESGRO.  Four to eight hours after seeding, cells were 
transfected with 8 µl Transfectin (Bio-Rad) and either 30 pmoles Stealth RNAi 
(Invitrogen), FAM labelled negative control siRNA (Ambion), or mock transfection 
without nucleotide diluted in Opti-Mem I (Gibco).  Sequences for siRNA designs are 
listed in Table 2. Negative control cells seeded identically, but untransfected, served 
to establish basal transcript expression levels.  Cells were collected at both 12 and 24 
hours post-transfection, with ES cell media change at 12 hours. For RNA isolation, 
cells were harvested following 1x PBS wash and lysed with 500 µl Trizol (Invitrogen) 
and RNA was extracted using phenol choloroform phase separation.  For Western 
blotting, 2% SDS was added and cell lysate was homogenized using high speed 
vortexing following addition of glass beads.  For trophectoderm differentiation, 
mESC were trypsinized 3 days post transfection and seeded in 3 mL mESC cell 
culture media onto 0.1% gelatinized coated 6-well plates to avoid overgrowth with 
daily mESC media replacement.    
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Table 2 siRNA designs 
 
 
Real-Time PCR Transcript Detection of Oct-3/4, Sox-2 and Canonical Targets of 
Cooperative Activity 
 
Four µg total RNA was reversed transcribed using MMLV-RT (Promega) in 54 µl 
reaction, 2 µl of which were used in a single qRT-PCR reaction.  Measurement of 
initial knockdown of Oct-3/4 was performed using Taqman using Oct-3/4 specific 
probe (ABI cat. no. 4331182) and ABI Gapdh VIC endogenous control kit according 
to manufacturer protocol. Reported values are calculated using ∆∆Ct method, 
normalized against endogenous Gapdh and calibrated against FAM negative control 
(Livak and Schmittgen, 2001).  
 
For precise quantification two to three primer pairs were designed for each target, 
amplified using PCR from a mixed pool of cDNAs from undifferentiated mESC, 12 
and 24 hour post-transfection with either siOct or siSox mESC cDNAs.  Fragments 
were inspect for proper size and subsequently cloned into Promega pGEM-T EZ 
(Promega), linearized vector using TA cloning, quantitated using UV spectrometry, 
and digested using XmnI restriction enzyme (except for Fgf-4 which was linearized 
siRNA Design Gene Target / 5’ 
Start Position 
 
   
siOct-A Oct-3/4 / 712  CCCGGAAGAGAAAGCGAACUAGCAU 
siOct-B Oct-3/4 / 1151 GGUAGACAAGAGAACCUGGAGCUUU
siSox-A Sox-2 / 667 GCACAUGAAGGAGCACCCGGAUUAU 
siSox-B Sox-2 / 669  ACAUGAAGGAGCACCCGGAUUAUAA 
siSox-C Sox-2 / 1173 ACCUCCGGGACAUGAUCAGCAUGUA 
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using SacII as its amplicon contains an internal XmnI restriction site).  Digested 
vector was further run on gel electrophoresis to ensure identical concentrations and 
serial dilutions ranging from 108 – 104 molecules per microliter were prepared as 
standards.  Primers were then tested for efficiency and sensitivity with 3.34 being an 
ideal slope for optimally efficient primers and sensitivity as determined by primer-
dimer formation in non-template controls.  
 
Primers selected for real-time PCR are listed in Table 3. Samples were amplified in 
duplicate with a standard curve prepared as described above to mitigate any 
systematic variations in instrument readings or sample preparation.  For 
differentiation markers, reported values are calculated using ∆∆Ct method (Livak and 
Schmittgen, 2001).  Immunoblotting of primary antibodies were diluted as follows: 
Oct-3/4 (Santa Cruz, SC-5279) 1:1000, Sox-2 (Chemicon, AB5770) 1:1000, Vimentin 
(Boehringer, V9) 1:1000 and β-Actin (Chemicon, MAB1501) 1:2000.  
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Table 3. Primer sequences used for Real-Time PCR detection 
 
Gene  Amplification Region  Forward Primer /  
Reverse Primer  
   
Oct-3/4  1056 - 1153 CCCTCTGTTCCCGTCACTG /  
ACCTCCCTTGCCTTGGCT 
Sox-2  71 - 230  GAAAGAAAGGAGAGAAGTTTGGAG /  
ATCTGGCGGAGAATAGTTGGG 
Utf-1  865 - 1063  CACTTGGGCGACATCTCAAC /  
GGAGAAGAGGACTGATAACAAAGC 
Opn  600 - 682  ACAAGCAGACACTTTCACTCCA /  
ACCTCAGTCCATAAGCCAAGC 
Fgf-4  552 - 673 GCCTTTCTTTACCGACGAGTGTA /  
TCTTGGTCCGCCCGTTCTTA 
Fbx-15  214 - 305 CTATGATTGGCTGCGACAGAC /  
TAGTCCACCATTCTCCTGCC 
Nestin 1162 - 1305 TCCTCAGCCCAACATCCTT /  
AGGGAGCCTCAGACATAGGT 
Ptx-3 135-226 TGGAGTTTGGGCTGCTTGGT /   
ATGTTCTGGAAGCGGAGGGT 
Brachyury  1637 - 1832 TGAAGCCAAGGACAGAGAGAC /   
GGCAACAAGGGAGGACATTAG 
Gata-4 399 - 592  AGAGGTTTCTGCTTTGATGCTG /   
GCACGAGGCAGACAAGAACT 
Gapdh 465 - 599  GATGGGTGTGAACCACGAGAA /  
GATGGCATGGACTGTGGTCA 
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Kill-Curve Analysis and Stable Transfection of Tet-R using Lentiviral and Plasmid 
Delivery 
 
Kill curve analysis performed for ECO-PAK, E14 and AB2.2 mESC cells was done 
according to manufacturer instruction.  Briefly, for Blasticidin and Zeocin, cells were 
seeded at 30% confluency, left overnight with selection applied in separate 
experiments for Blasticidin concentrations ranging from 1-5 µg/mL (0, 1, 2.5, 5 
µg/mL) and Zeocin concentrations ranging from 50-1000 µg/mL (0, 50, 250, 500, 
1000 µg/mL).  Cells were observed continuously for one week with daily media 
change to determine lowest concentration necessary to completely eliminate viable 
cells and the next highest concentration was selected for further usage.    
 
Vector pLenti6/TR encoding Tet-R protein was propagated using Invitrogen OneShot 
competent cells and digested with Hind III and Bgl II to insure proper restriction 
mapping.  Packaging was done in ECO-PAK cells, previously seeded at 50% 
confluency, transfected with 4 µg GFP-C2 or pLenti6/TR plasmid and 15 µl 
Transfectin (Bio-Rad) per well.  Selection was applied 48 hours post-transfection with 
daily media change until stable colonies were observed.  Stable colonies were 
expanded for an additional week.  Following storage as frozen stocks, cells (ECO-
PAK/TR) were expanded with viral supernatant collected for transduction of mESC.  
Transduction was done according to manufacturer protocol.   
 
Eukaryotic expression vector encoding Tetracyline Repressor (TetR), pcDNA6/TR 
(Invitrogen), was propagated using OneShot competent cells (Invitrogen) and 
transfected using 4 µg plasmid and 15µl Transfectin (Bio-Rad) into 5x105 ES cells 
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seeded onto 6-well gelatin coated plates as described above.  Embryonic stem cell 
media was changed and 5 µg/mL Blasticidin S (Invitrogen) selection was applied 24 
and 48 hours post-transfection, respectively.  Cells were left for five days with daily 
ES cell media (including Blasticidin selection, ES-Blast) replacement before being 
trypsinized with 100 µl Typsin, quenching with 900 µl ES-Blast media and seeding 
onto gelatin coated T75 flasks in a total volume of 8 mL ES-Blast media.  
Independent well transfection were designated as either “A” or “B” as carried forward 
as clonal lines.   
 
Generation of Inducible, Stable Short Hairpin TetR ES Cell Lines  
 
Inducible, stable short hairpin TetR ES cell lines specifically targeting Oct-3/4 or 
Sox-2 were generated using pEntr H1/TO vector (Invitrogen) containing a 59-bp 
annealed duplex oligo previously ligated, cloned and screened using sequence 
verification.  Embryonic stem cells were seeded, transfected and selected in an 
identical manner as TetR ES host lines with 500 ug/mL Zeocin selection applied (ES-
Blast-Zeo).  Cassette design was based on siRNA sequences described above with 
“shOct1” cassette containing same 21-bp sense sequence as “siOct-A” (shOct2 
corresponds to siOct-B) for all constructs reported (Table 4), followed by originating 
clone designation (ie, “O1-4” designates clone 4)  and “x” and “y” designations for 
independent well transfections carried forward as clonal lines.  Two cassette designs 
for Oct-3/4 were separately engineered into E14 and AB2.2 cell lines to minimize 
non-specific effects potentially originating from either design.     
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Induction of stable knockdown was observed by addition of 1 µg/mL tetracycline (Tc) 
to ES-Blast-Zeo media and detection using Western blot after three days.  RNAi 
mediated SDIA using heparin-NIF was performed as described above with Tc added 
either during seeding (day 0) or excluded from control cells as indicated.    
 
Table 4 shRNA cassette designs 
 
 
Purple denotes ligation adapter   Green denotes sense sequence  
Black denotes hairpin   Red denotes inverted repeat sequence 
shRNA Design Cassette Sequence 
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Alpha Mem     450 mL 
10% FBS    50 mL 




Glasgow Media    435 mL 
10% Knock-Out Serum  50 mL 
10 mM Non-Essential Amino Acid 5 mL 
200 mM L-Glutamine   5 mL 
100 mM Sodium Pyruvate  5 mL 
14.3 M β-Mercaptoethanol  3.5 µL 
 
ES Cell Culture Media 
 
High Glucose D-Mem  420 mL 
15% FBS    75 mL 
100x Glu-Pen-Strep   5.74 mL 
14.3 M β-Mercaptoethanol  5.74 µL 
LIF-ESGRO (107 U / mL)   50 µL  
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